No tags found.
No abstract available.
Citation
Wu HT, Wu Z, Hou YY, Fang ZX, Wu BX, Deng Y, Cui YK, Liu J. SIX4, a potential therapeutic target for estrogen receptor-positive breast cancer patients, is associated with low promoter methylation level. Epigenomics. 2023 Sep;15(18):911-925
PMID: 0
View Full Text
